Matches in Wikidata for { <http://www.wikidata.org/entity/Q53648839> ?p ?o ?g. }
- Q53648839 description "2015 nî lūn-bûn" @default.
- Q53648839 description "2015 թվականի հունվարի 8-ին հրատարակված գիտական հոդված" @default.
- Q53648839 description "2015年の論文" @default.
- Q53648839 description "2015年学术文章" @default.
- Q53648839 description "2015年学术文章" @default.
- Q53648839 description "2015年学术文章" @default.
- Q53648839 description "2015年学术文章" @default.
- Q53648839 description "2015年学术文章" @default.
- Q53648839 description "2015年学术文章" @default.
- Q53648839 description "2015年學術文章" @default.
- Q53648839 description "2015年學術文章" @default.
- Q53648839 description "2015年學術文章" @default.
- Q53648839 description "2015年學術文章" @default.
- Q53648839 description "2015年學術文章" @default.
- Q53648839 description "2015년 논문" @default.
- Q53648839 description "article científic" @default.
- Q53648839 description "article scientific" @default.
- Q53648839 description "article scientifique" @default.
- Q53648839 description "articol științific" @default.
- Q53648839 description "articolo scientifico" @default.
- Q53648839 description "artigo científico" @default.
- Q53648839 description "artigo científico" @default.
- Q53648839 description "artigo científico" @default.
- Q53648839 description "artikel ilmiah" @default.
- Q53648839 description "artikull shkencor" @default.
- Q53648839 description "artikulong pang-agham" @default.
- Q53648839 description "artykuł naukowy" @default.
- Q53648839 description "artículo científico publicado en 2015" @default.
- Q53648839 description "artículu científicu" @default.
- Q53648839 description "bilimsel makale" @default.
- Q53648839 description "bài báo khoa học" @default.
- Q53648839 description "naučni članak" @default.
- Q53648839 description "scienca artikolo" @default.
- Q53648839 description "scientific article published on 8 January 2015" @default.
- Q53648839 description "scientific article published on 8 January 2015" @default.
- Q53648839 description "scientific article published on 8 January 2015" @default.
- Q53648839 description "teaduslik artikkel" @default.
- Q53648839 description "tieteellinen artikkeli" @default.
- Q53648839 description "tudományos cikk" @default.
- Q53648839 description "vedecký článok" @default.
- Q53648839 description "vetenskaplig artikel" @default.
- Q53648839 description "videnskabelig artikel" @default.
- Q53648839 description "vitenskapelig artikkel" @default.
- Q53648839 description "vitskapeleg artikkel" @default.
- Q53648839 description "vědecký článek" @default.
- Q53648839 description "wetenschappelijk artikel" @default.
- Q53648839 description "wissenschaftlicher Artikel" @default.
- Q53648839 description "επιστημονικό άρθρο" @default.
- Q53648839 description "мақолаи илмӣ" @default.
- Q53648839 description "наукова стаття, опублікована в січні 2015" @default.
- Q53648839 description "научна статия" @default.
- Q53648839 description "научная статья" @default.
- Q53648839 description "научни чланак" @default.
- Q53648839 description "научни чланак" @default.
- Q53648839 description "מאמר מדעי" @default.
- Q53648839 description "مقالة علمية نشرت في 8 يناير 2015" @default.
- Q53648839 description "৮ জানুয়ারি ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53648839 description "บทความทางวิทยาศาสตร์" @default.
- Q53648839 description "სამეცნიერო სტატია" @default.
- Q53648839 name "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression." @default.
- Q53648839 name "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression." @default.
- Q53648839 type Item @default.
- Q53648839 label "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression." @default.
- Q53648839 label "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression." @default.
- Q53648839 prefLabel "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression." @default.
- Q53648839 prefLabel "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression." @default.
- Q53648839 P1433 Q53648839-5C34707F-8B83-4B19-9BFE-F92B6AD5D6BE @default.
- Q53648839 P1476 Q53648839-08A66D30-2264-4833-8B15-E5135BC15855 @default.
- Q53648839 P2093 Q53648839-69EE13F3-8C17-451E-B7F1-0E3CB73D88AA @default.
- Q53648839 P2093 Q53648839-6F5861AB-98C6-4C85-9527-1560FD30730A @default.
- Q53648839 P2093 Q53648839-79509162-B9C3-4308-8B6D-5DE5BE6B7DCB @default.
- Q53648839 P2093 Q53648839-A1DFDD2B-6D43-4CF0-9754-1E0B235504FD @default.
- Q53648839 P2093 Q53648839-A2CE216E-2CFC-43B6-8649-6DE3A9190B40 @default.
- Q53648839 P2093 Q53648839-A646D9E3-C460-419C-BFD5-AE2C5F7F7DF3 @default.
- Q53648839 P2093 Q53648839-A9521111-D172-4F78-9209-50C4842EBBB0 @default.
- Q53648839 P2093 Q53648839-D4C6F801-C5A9-4990-9349-01473D5D6D69 @default.
- Q53648839 P2093 Q53648839-D6FC5B17-1E82-4563-8297-AB7BDC2D97EA @default.
- Q53648839 P2093 Q53648839-DF3FDF2C-3204-4E97-805A-2050090CD574 @default.
- Q53648839 P304 Q53648839-2CDFE2B0-DBDD-401D-979C-56B7BF6C2ADC @default.
- Q53648839 P31 Q53648839-43CDC266-C2AA-40B6-B392-70BA0E678565 @default.
- Q53648839 P356 Q53648839-6FF86CB6-4D22-47E1-98B2-77A3D8CDF191 @default.
- Q53648839 P407 Q53648839-437457BC-DBCC-4563-93B4-2BAAEDDA27FE @default.
- Q53648839 P433 Q53648839-2871EC55-BADB-423E-A4C5-D58DF18DF51F @default.
- Q53648839 P478 Q53648839-B9ABD7D7-31F4-4814-ADFC-C83539AD9E28 @default.
- Q53648839 P50 Q53648839-85557BA5-D7AC-4A7F-BBB5-C9ACE2208299 @default.
- Q53648839 P50 Q53648839-D70CADB5-06F0-4F48-804F-04D8B1EA3E13 @default.
- Q53648839 P577 Q53648839-B6010038-EF81-4270-B4DE-5CCEAC35C1FD @default.
- Q53648839 P5875 Q53648839-CE6EE1D8-F10C-446A-9461-61F04048FF62 @default.
- Q53648839 P698 Q53648839-7F7C12B6-D84B-48CA-B28D-22D6D0F839E2 @default.
- Q53648839 P356 BLOOD-2014-09-598763 @default.
- Q53648839 P698 25573987 @default.
- Q53648839 P1433 Q885070 @default.
- Q53648839 P1476 "Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression" @default.
- Q53648839 P2093 "Celeste M Bello" @default.
- Q53648839 P2093 "Dana A Kennedy" @default.
- Q53648839 P2093 "Eric D Jacobsen" @default.
- Q53648839 P2093 "Gary Spitzer" @default.
- Q53648839 P2093 "Jane N Winter" @default.
- Q53648839 P2093 "Jeff P Sharman" @default.
- Q53648839 P2093 "Jing Yang" @default.